Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-3,870
Closed -$421K 95
2018
Q4
$421K Hold
3,870
0.04% 64
2018
Q3
$559K Hold
3,870
0.05% 56
2018
Q2
$517K Sell
3,870
-1,255
-24% -$175K 0.05% 58
2018
Q1
$752K Hold
5,125
0.07% 45
2017
Q4
$752K Hold
5,125
0.07% 45
2017
Q3
$711K Buy
+5,125
New +$714K 0.07% 45
2017
Q2
Sell
-3
Closed -$1K 188
2017
Q1
$1K Buy
+3
New +$503 ﹤0.01% 184
2016
Q4
Sell
-5,125
Closed -$778K 172
2016
Q3
$778K Hold
5,125
0.16% 37
2016
Q2
$744K Hold
5,125
0.14% 39
2016
Q1
$742K Buy
+5,125
New +$655K 0.14% 39
2015
Q1
Sell
-14,586
Closed -$2.24M 184
2014
Q4
$2.24M Sell
14,586
-665
-4% -$106K 0.52% 35
2014
Q3
$2.77M Sell
15,251
-125
-0.8% -$22.8K 0.46% 39
2014
Q2
$2.67M Buy
+15,376
New +$2.77M 0.37% 43
2014
Q1
Sell
-15,468
Closed -$2.77M 655
2013
Q4
$2.77M Hold
15,468
0.37% 36
2013
Q3
$2.74M Buy
15,468
+14,278
+1,200% +$2.6M 0.44% 37
2013
Q2
$217K Buy
+1,190
New +$232K 2.51% 13

Other funds holding IBM

Hirtle Callaghan & Co's IBM Position: Q1 2019 in Review

Hirtle Callaghan & Co sold out of IBM (IBM) in Q1 2019, closing a stake of 3,870 shares — an estimated $421K sold.

Hirtle Callaghan & Co first reported a position in IBM in Q2 2013 and held it in 16 quarters. The position peaked at $2.77M in Q4 2013. 1,974 funds tracked by Wall St. Rank hold IBM as of Q1 2019.

  • Hirtle Callaghan & Co reported no remaining IBM position as of Q1 2019 after selling out during the quarter.
  • Hirtle Callaghan & Co sold 3,870 IBM shares in Q1 2019, an estimated $421K.
  • Hirtle Callaghan & Co first reported a position in IBM in Q2 2013 and held it in 16 quarters.
  • Hirtle Callaghan & Co's IBM position peaked at $2.77M in Q4 2013.
  • 1,974 funds tracked by Wall St. Rank held IBM as of Q1 2019.

Based on Hirtle Callaghan & Co's 13F filing for Q1 2019, filed 14 May 2019.